\n
![\"EarthSnap\"\/](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/12\/1766650691_946_earthsnap-banner-news.webp.webp\")
\n<\/a><\/p>\n
The recalled product\u2019s scientific names are bisoprolol fumarate and hydrochlorothiazide tablets, sold as Ziac, in 2.5 mg\/6.25 mg doses.<\/p>\n
Oversight comes from the United States Food and Drug Administration (FDA<\/a>), and its recall guidance helps patients respond calmly.<\/p>\n Inside FDA, the Center for Drug Evaluation and Research focuses on drug safety and quality, and it works with firms on fixes.<\/p>\n Triggering the Ziac recall<\/p>\n Testing found ezetimibe<\/a>, a drug that reduces cholesterol absorption in the intestine, and Glenmark began the recall.<\/p>\n The company first pulled product on November 21, 2025, after checking reserve samples, saved pills used to recheck a batch.<\/p>\n Regulators later posted it as low risk on December 1, 2025, and paperwork on the bottle remains the best way to spot it.<\/p>\n Cross-contamination can happen when a factory makes several drugs on shared lines and a cleaning step misses tiny residues.<\/p>\n Packaging errors also occur, since tablets and bottles move fast through machines<\/a> that rely on correct parts and labels.<\/p>\n Even when trace amounts appear, quality teams treat the finding seriously because it signals a process that needs tightening.<\/p>\n What the medications does<\/p>\n Ziac treats hypertension using bisoprolol, a beta-blocker<\/a>, a drug that slows heart and lowers pressure, plus hydrochlorothiazide.<\/p>\n Hydrochlorothiazide is a diuretic, a medicine that increases urination to reduce fluid, which can lower blood pressure.<\/p>\n Because it combines two drugs, prescribers watch for low potassium, dizziness, or slow pulse when doses change.<\/p>\n Ezetimibe is not prescribed for everyone, so even small mix-ups can surprise patients who never agreed to take it.<\/p>\n Most people would notice nothing, but some could face new side effects, allergy concerns, or drug<\/a> interactions with other prescriptions.<\/p>\n Recalls also matter for trust, since patients depend on each tablet containing only what the pharmacist and prescriber expected.<\/p>\n What Class III means<\/p>\n FDA defines Class III<\/a>, the lowest-risk recall category for consumers, as \u201cnot likely to cause adverse health consequences\u201d for most users.<\/p>\n A Class III label does not mean no mistake happened, but it suggests serious harm is unlikely for most people.<\/p>\n Class I and Class II recalls sit higher on the hazard scale, so they usually trigger louder public warnings.<\/p>\n Ziac bottle recall numbers<\/p>\n Look for the NDC, a code that identifies a drug and package, on the pharmacy label or bottle. The recalled 30-count bottle uses NDC 68462-878-30, and the 100-count bottle uses NDC 68462-878-01 too.<\/p>\n A 500-count bottle uses NDC 68462-878-05, and the lot number, the batch identifier used to trace production, is 17232401 or 17240974.<\/p>\n If your code matches, call your pharmacy first, since staff can tell you whether a replacement is available quickly.<\/p>\n Contact the clinician who prescribes your blood-pressure medicine, and ask whether you should switch brands or keep taking it.<\/p>\n New symptoms should be reported to MedWatch, FDA<\/a>\u2018s program for reporting side effects and product problems, even when risk seems low.<\/p>\n The Ziac label warns that stopping beta-blockers abruptly can worsen chest pain and may trigger heart attack or rhythm problems.<\/p>\n For many patients, clinicians taper the dose over about one week, which lowers withdrawal risk and keeps pressure stable.<\/p>\n A recall<\/a> can also disrupt refills, so patients should request prescriptions early and avoid running out over weekends.<\/p>\n Why recalls feel sudden<\/p>\n Companies often detect problems during internal checks, then alert wholesalers and pharmacies before most patients hear anything.<\/p>\n Class III actions may stay mostly in supply chains, and many patients keep taking medicine unless told otherwise.<\/p>\n Still, a short headline can spread fast online, and it rarely explains the difference between low and high-hazard recalls.<\/p>\n FDA publishes weekly enforcement reports that log classified recalls<\/a>, even when no public alert seems necessary.<\/p>\n Staff consider what could happen if the product is used, how widely it traveled, and who might take it.<\/p>\n A record can change as firms test samples, widen affected lots, or confirm that a limited batch caused trouble.<\/p>\n Quality-control pressure<\/p>\n Current good manufacturing practices are often shortened to cGMP in inspection reports. When plants handle many products, cGMP requires strong cleaning checks, clear paperwork, and separation that prevents mix-ups.<\/p>\n Those rules also push companies to keep reserve samples, track lot numbers, and prove that each step stayed under control.<\/p>\n A 2024 analysis<\/a> reviewed 15,710 FDA recall observations from June 2012 to August 2023 and mapped the most frequent causes.<\/p>\n In that work, sterility was the most common issue across drug categories. The authors tied 48% of sterility recalls to assurance gaps and 45% to non-sterility, then flagged nitroso-amines, chemicals that form drug impurities.<\/p>\n Ziac recall takeaways<\/p>\n The affected bottles carry expiration dates from November 2025 through May 2026, so they may still sit in cabinets today.<\/p>\n Keeping a current medication list, including dose and pharmacy, makes it easier to act fast when a recall<\/a> notice appears.<\/p>\n If you feel unwell after any medicine change, write down symptoms and timing, since details help clinicians judge cause.<\/p>\n This recall is labeled low risk, but it still asks patients to check codes and confirm next steps with professionals.<\/p>\n Recalls cannot undo a manufacturing slip, yet they can limit exposure and push companies to tighten systems under cGMP rules.<\/p>\n \u2014\u2013<\/p>\n Like what you read? Subscribe to our newsletter<\/a> for engaging articles, exclusive content, and the latest updates.<\/p>\n Check us out on EarthSnap<\/a>, a free app brought to you by Eric Ralls<\/a> and Earth.com.<\/p>\n \u2014\u2013<\/p>\n","protected":false},"excerpt":{"rendered":"Glenmark Pharmaceuticals in New Jersey is recalling over 11,000 bottles of a blood-pressure medication, ziac, for cross-contamination concerns.…\n","protected":false},"author":2,"featured_media":405319,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,137,490,128],"class_list":{"0":"post-405318","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-au","9":"tag-australia","10":"tag-health","11":"tag-medication","12":"tag-science"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/405318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=405318"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/405318\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/405319"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=405318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=405318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=405318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}